Corteva, Inc. (NYSE:CTVA) Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC trimmed its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 4.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 662,618 shares of the company's stock after selling 31,783 shares during the period. Cambiar Investors LLC owned about 0.09% of Corteva worth $31,753,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its stake in shares of Corteva by 2.4% during the third quarter. Vanguard Group Inc. now owns 81,346,924 shares of the company's stock worth $4,161,709,000 after buying an additional 1,941,323 shares during the period. Geode Capital Management LLC raised its holdings in shares of Corteva by 1.4% during the first quarter. Geode Capital Management LLC now owns 14,726,824 shares of the company's stock worth $886,490,000 after purchasing an additional 208,948 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Corteva by 2.7% during the third quarter. Northern Trust Corp now owns 12,505,783 shares of the company's stock worth $639,796,000 after purchasing an additional 327,321 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Corteva by 29.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 11,095,076 shares of the company's stock worth $567,624,000 after purchasing an additional 2,545,570 shares during the last quarter. Finally, Morgan Stanley raised its holdings in shares of Corteva by 8.6% during the fourth quarter. Morgan Stanley now owns 9,452,940 shares of the company's stock worth $555,644,000 after purchasing an additional 746,972 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CTVA shares. Barclays raised their target price on shares of Corteva from $50.00 to $55.00 and gave the stock an "equal weight" rating in a report on Friday, February 2nd. Wolfe Research started coverage on shares of Corteva in a report on Friday, March 1st. They set an "outperform" rating and a $67.00 target price for the company. Oppenheimer raised their target price on shares of Corteva from $60.00 to $62.00 and gave the stock an "outperform" rating in a report on Friday, February 2nd. Wells Fargo & Company raised their target price on shares of Corteva from $54.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, February 2nd. Finally, UBS Group cut their price objective on shares of Corteva from $65.00 to $64.00 and set a "buy" rating for the company in a report on Thursday, January 11th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $63.14.

Corteva Price Performance

Shares of CTVA stock traded down $0.10 on Friday, reaching $56.85. 2,226,724 shares of the company were exchanged, compared to its average volume of 3,365,418. The company has a market cap of $39.73 billion, a price-to-earnings ratio of 55.74, a P/E/G ratio of 1.46 and a beta of 0.77. The business has a 50-day moving average price of $54.38 and a 200 day moving average price of $49.99. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56. Corteva, Inc. has a 1 year low of $43.22 and a 1 year high of $63.37.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.09. The firm had revenue of $3.71 billion for the quarter, compared to analyst estimates of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same period in the previous year, the business posted $0.16 earnings per share. Equities research analysts forecast that Corteva, Inc. will post 2.87 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $0.64 dividend on an annualized basis and a yield of 1.13%. Corteva's payout ratio is presently 62.75%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.